Broker recommendations can be a useful early clue in the hunt for stocks to add to your portfolio. These city analysts know the companies they cover better than most, so their views on whether to buy or sell them are worth considering....
|Type||Buy / Hold / Sell|
|Year End 31st Mar||Unit||2018||2019||2020||2021||2022||2023E||2024E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for AGR
Broker recommendations can be a useful early clue when it comes to finding stocks to buy. But even company analysts can get things wrong, which means that when it comes to listening to these experts, it pays to explore the big picture....
The Assura (LON:AGR) share price has risen by 2.12% over the past month and it’s currently trading at 77.6111. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue....
Shares in Assura (LON:AGR) are currently trading close to a 52 week high, with the share price up by around 1.23% - to 81.5 - over the past week. On a one-month basis, the Assura share price has risen by 1.48%. For investors holding th...
The Assura (LON:AGR) share price has risen by 1.48% over the past month and it’s currently trading at 81.5. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue. Acc...
Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company is specialized in the development of, investment in and management of, a portfolio of primary care, community, diagnostic and treatment buildings across the United Kingdom. The Group owns and manages a portfolio of 625 modern primary healthcare properties. The Company's subsidiaries include Apollo Capital Projects Development Ltd, Assura Trellech Ltd, Newton Healthcare Ltd, Assura (SC1) Ltd, BHE (Heartlands) Ltd, Park Medical Services Ltd, Assura (SC2) Ltd, BHE (St James) Ltd, Pentagon HS Ltd, Assura Aspire Ltd, Bicester HC Developments Ltd, Prime Hereford Hub Ltd, Assura Aspire UK Ltd, Cheltenham Family Health Care Centre Ltd, Prospect Medical (Malvern) Ltd, Assura Development Hub Ltd, Community Ventures Windmill Ltd, Ridge Medical Ltd, Assura GHC Ltd, Donnington Healthcare Ltd and Shotfield Development Business Partnership Ltd.
- The Brew House, Greenalls Avenue, WARRINGTON, WA4 6HL
- +44 1925420660
- David Purcell
- Ernst & Young LLP
Latest News for AGR
Upcoming Events for AGR
Full Year 2022 Assura PLC Investor Meeting
Dividend For AGRP.L - 0.7800 GBX
Assura PLC Annual Shareholders Meeting
Assura PLC Annual Shareholders Meeting
Half Year 2023 Assura PLC Earnings Release
As of Today at 07:02 UTC, shares in Assura are trading at 69.90p. This share price information is delayed by 15 minutes.
Shares in Assura last closed at 69.90p and the price had moved by -4.9% over the past 365 days. In terms of relative price strength the Assura share price has underperformed the FTSE All Share Index by -7.59% over the past year.
The overall consensus recommendation for Assura is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Assura dividend yield is 3.81% based on the trailing twelve month period.
Last year, Assura paid a total dividend of £0.03, and it currently has a trailing dividend yield of 3.81%. We do not have any data on when Assura is to next pay dividends.
We do not have data on when Assura is to next pay dividends. The historic dividend yield on Assura shares is currently 3.81%.
To buy shares in Assura you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 69.90p, shares in Assura had a market capitalisation of £2.07bn.
Here are the trading details for Assura:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: AGR
Based on an overall assessment of its quality, value and momentum Assura is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Assura is 77.51p. That is 10.88% above the last closing price of 69.90p.
Analysts covering Assura currently have a consensus Earnings Per Share (EPS) forecast of £0.03 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Assura. Over the past six months, its share price has underperformed the FTSE All Share Index by -3.13%.
As of the last closing price of 69.90p, shares in Assura were trading +0.49% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Assura PE ratio based on its reported earnings over the past 12 months is 21.51. The shares last closed at 69.90p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Assura's management team is headed by:
- Ed Smith - NEC
- Jonathan Murphy - CEO
- Jayne Cottam - CFO
- Orla Ball - SEC
- Sam Barrell - NED
- Emma Cariaga - NED
- Noel Gordon - NED
- Jonathan Davies - NID
- Louise Fowler - NID